应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06660 艾美疫苗
未开盘 12-19 16:08:47
6.100
-0.090
-1.45%
最高
6.200
最低
5.920
成交量
150.66万
今开
6.200
昨收
6.190
日振幅
4.52%
总市值
73.87亿
流通市值
30.01亿
总股本
12.11亿
成交额
911.77万
换手率
0.31%
流通股本
4.92亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
艾美疫苗(06660.HK)第二代破伤风疫苗获临床试验许可
阿斯达克财经 · 01:07
艾美疫苗(06660.HK)第二代破伤风疫苗获临床试验许可
艾美疫苗(06660.HK)MDCK细胞流感疫苗获临床试验许可
阿斯达克财经 · 12-19 23:40
艾美疫苗(06660.HK)MDCK细胞流感疫苗获临床试验许可
港股公告掘金 | 艾美疫苗:第二代高效价吸附破伤风疫苗获得临床试验许可
智通财经 · 12-19 23:03
港股公告掘金 | 艾美疫苗:第二代高效价吸附破伤风疫苗获得临床试验许可
艾美疫苗(06660):第二代高效价吸附破伤风疫苗获得临床试验许可
智通财经 · 12-19 21:27
艾美疫苗(06660):第二代高效价吸附破伤风疫苗获得临床试验许可
艾美疫苗:新技术路线悬浮培养四价MDCK细胞流感疫苗获临床试验许可
智通财经 · 12-19 19:49
艾美疫苗:新技术路线悬浮培养四价MDCK细胞流感疫苗获临床试验许可
艾美疫苗(06660):新技术路线悬浮培养四价MDCK细胞流感疫苗获临床试验许可
智通财经 · 12-19 18:12
艾美疫苗(06660):新技术路线悬浮培养四价MDCK细胞流感疫苗获临床试验许可
艾美疫苗(06660)下跌5.09%,报6.15元/股
金融界 · 12-17 14:44
艾美疫苗(06660)下跌5.09%,报6.15元/股
艾美疫苗盘中异动 下午盘大幅下挫5.09%报6.150港元
市场透视 · 12-17 14:44
艾美疫苗盘中异动 下午盘大幅下挫5.09%报6.150港元
南向资金12月13日净卖出艾美疫苗17.22万股 连续7日减持
市场透视 · 12-16
南向资金12月13日净卖出艾美疫苗17.22万股 连续7日减持
南向资金12月11日净卖出艾美疫苗29.82万股 连续5日减持
市场透视 · 12-12
南向资金12月11日净卖出艾美疫苗29.82万股 连续5日减持
艾美疫苗12月10日遭主力抛售116万元 环比增加107.14%
市场透视 · 12-10
艾美疫苗12月10日遭主力抛售116万元 环比增加107.14%
南向资金12月9日净卖出艾美疫苗9.66万股 连续3日减持
市场透视 · 12-10
南向资金12月9日净卖出艾美疫苗9.66万股 连续3日减持
艾美疫苗12月09日主力资金流出56万元 连续3日减仓
市场透视 · 12-09
艾美疫苗12月09日主力资金流出56万元 连续3日减仓
南向资金12月4日净买入艾美疫苗2.52万股 连续3日增持
市场透视 · 12-05
南向资金12月4日净买入艾美疫苗2.52万股 连续3日增持
艾美疫苗11月28日遭主力抛售44万元 环比增加780.00%
市场透视 · 11-28
艾美疫苗11月28日遭主力抛售44万元 环比增加780.00%
艾美疫苗盘中异动 早盘股价大涨5.04%
市场透视 · 11-27
艾美疫苗盘中异动 早盘股价大涨5.04%
港股异动 | 艾美疫苗(06660)午前飙升近14% 两大重磅疫苗接近上市 公司近日迎来多家机构调研
智通财经 · 11-26
港股异动 | 艾美疫苗(06660)午前飙升近14% 两大重磅疫苗接近上市 公司近日迎来多家机构调研
艾美疫苗(06660)股价显著上升11.321%,现价港币$7.67
阿斯达克财经 · 11-26
艾美疫苗(06660)股价显著上升11.321%,现价港币$7.67
艾美疫苗(06660)上涨5.08%,报7.24元/股
金融界 · 11-26
艾美疫苗(06660)上涨5.08%,报7.24元/股
艾美疫苗盘中异动 下午盘股价大涨5.03%报6.890港元
市场透视 · 11-25
艾美疫苗盘中异动 下午盘股价大涨5.03%报6.890港元
公司概况
公司名称:
艾美疫苗
所属市场:
SEHK
上市日期:
--
主营业务:
艾美疫苗股份有限公司是一家主要从事疫苗研发、制造和销售的中国公司。该公司的产品主要包括重组乙型肝炎疫苗、人用狂犬病疫苗、甲型肝炎灭活疫苗、腮腺炎疫苗、肾综合征出血热灭活疫苗和MPSV4。该公司的产品主要用于治疗乙肝、甲肝、腮腺炎、肾综合征出血热、狂犬病和脑膜炎球菌病。该公司的在研疫苗包括信使核糖核酸(mRNA)新冠(COVID-19)疫苗、灭活新冠疫苗、广谱新冠疫苗、PCV13、PPSV23及MCV4。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"06660","market":"HK","secType":"STK","nameCN":"艾美疫苗","latestPrice":6.1,"timestamp":1734595727019,"preClose":6.19,"halted":0,"volume":1506600,"delay":0,"floatShares":492000000,"shares":1211062599,"eps":-1.1523882,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.09,"latestTime":"12-19 16:08:47","open":6.2,"high":6.2,"low":5.92,"amount":9117686,"amplitude":0.045234,"askPrice":6.1,"askSize":4800,"bidPrice":6.04,"bidSize":14600,"shortable":3,"etf":0,"ttmEps":-1.0539661141972907,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734658200000},"adr":0,"listingDate":1664985600000,"adjPreClose":6.19,"openAndCloseTimeList":[[1734571800000,1734580800000],[1734584400000,1734595200000]],"volumeRatio":0.830247,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06660/wiki","defaultTab":"wiki","newsList":[{"id":"2492015781","title":"艾美疫苗(06660.HK)第二代破伤风疫苗获临床试验许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2492015781","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492015781?lang=zh_cn&edition=full","pubTime":"2024-12-20 01:07","pubTimestamp":1734628020,"startTime":"0","endTime":"0","summary":"艾美疫苗(06660.HK) 公布,集团第二代高效价吸附破伤风疫苗已获国家药品监督管理局《药物临床试验批准通知书》,标志该疫苗的研发进入了新的阶段。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-12-19 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20221108125356139_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20221108125356139_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1405384/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1141","03347","BK1583","06660","BK1576","159646","BK1161"],"gpt_icon":0},{"id":"2492170159","title":"艾美疫苗(06660.HK)MDCK细胞流感疫苗获临床试验许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2492170159","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492170159?lang=zh_cn&edition=full","pubTime":"2024-12-19 23:40","pubTimestamp":1734622800,"startTime":"0","endTime":"0","summary":"艾美疫苗(06660.HK) 公布,集团新技术路线悬浮培养四价MDCK细胞流感疫苗,近日获得国家药品监督管局《药物临床试验批准通知书》,标志该疫苗的研发进入新阶段。MDCK细胞流感疫苗作为重磅大单品,该款产品上市后有望成为集团新的业绩增长点。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-12-19 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20200103175221798_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20200103175221798_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1405359/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1141","03347","BK1583","06660","BK1576","BK1161"],"gpt_icon":0},{"id":"2492172338","title":"港股公告掘金 | 艾美疫苗:第二代高效价吸附破伤风疫苗获得临床试验许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2492172338","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492172338?lang=zh_cn&edition=full","pubTime":"2024-12-19 23:03","pubTimestamp":1734620622,"startTime":"0","endTime":"0","summary":"【重大事项】华人置业(00127)附属拟1.62亿英镑出售英国伦敦物业狮腾控股(02562)拟与新加坡艺人管理媒体公司等联合举办真人秀项目《SuperStreamer Asia》艾美疫苗(06660):第二代高效价吸附破伤风疫苗获得临床试验许可艾美疫苗(06660):新技术路线悬浮培养四价MDCK细胞流感疫苗获临床试验许可未来数据集团(08229)就发展低空经济业务订立多项战略合作连连数字(025","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227368.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1216","06660","159646","BK1583","02562","BK1141","08229","BK1253","YANG","HSCEI","HSTECH","BK1155","03347","BK1576","02598","BK1161","00127","BK1601"],"gpt_icon":1},{"id":"2492912071","title":"艾美疫苗(06660):第二代高效价吸附破伤风疫苗获得临床试验许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2492912071","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492912071?lang=zh_cn&edition=full","pubTime":"2024-12-19 21:27","pubTimestamp":1734614874,"startTime":"0","endTime":"0","summary":"智通财经APP讯,艾美疫苗 公布,该集团第二代高效价吸附破伤风疫苗已于近日获得国家药品监督管理局《药物临床试验批准通知书》,标志着该疫苗的研发进入了新的阶段。破伤风是一种极为严重的潜在致命性疾病,目前接种破伤风疫苗是预防破伤风最经济有效的措施。其中,四联疫苗用于预防百日咳、白喉、破伤风和b型流感嗜血杆菌引起的侵入性感染,具有减少婴幼儿的接种针次,增强家长和婴幼儿接种依从性等优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227334.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1583","03347","BK1576","159646","BK1161","06660"],"gpt_icon":0},{"id":"2492104121","title":"艾美疫苗:新技术路线悬浮培养四价MDCK细胞流感疫苗获临床试验许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2492104121","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492104121?lang=zh_cn&edition=full","pubTime":"2024-12-19 19:49","pubTimestamp":1734608940,"startTime":"0","endTime":"0","summary":"艾美 疫苗 (06660.HK)发布公告,集团新技术路线悬浮培养四价MDCK细胞流感疫苗,已于近日获得国家药品监督管理局《药物临床试验批准通知书》,标志着该疫苗的研发进入了新的阶段。目前,国内上市的流感疫苗均基于鸡胚工艺生产,尚无基于细胞基质的流感疫苗获批上市。MDCK细胞流感疫苗作为重磅大单品,该款产品上市后有望成为集团新的业绩增长点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219200056a1fb1379&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219200056a1fb1379&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1161","BK1141","BK1583","06660","03347"],"gpt_icon":0},{"id":"2492314147","title":"艾美疫苗(06660):新技术路线悬浮培养四价MDCK细胞流感疫苗获临床试验许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2492314147","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492314147?lang=zh_cn&edition=full","pubTime":"2024-12-19 18:12","pubTimestamp":1734603162,"startTime":"0","endTime":"0","summary":"智通财经APP讯,艾美疫苗 发布公告,集团新技术路线悬浮培养四价MDCK细胞流感疫苗,已于近日获得国家药品监督管理局《药物临床试验批准通知书》,标志着该疫苗的研发进入了新的阶段。MDCK细胞流感疫苗作为重磅大单品,该款产品上市后有望成为集团新的业绩增长点。与传统的鸡胚流感裂解疫苗相比,集团研发的MDCK细胞流感疫苗,在产品质量和安全性方面均得到显著提高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227149.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","BK1583","BK1141","BK1161","BK1576","06660"],"gpt_icon":0},{"id":"2492861769","title":"艾美疫苗(06660)下跌5.09%,报6.15元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492861769","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492861769?lang=zh_cn&edition=full","pubTime":"2024-12-17 14:44","pubTimestamp":1734417869,"startTime":"0","endTime":"0","summary":"12月17日,艾美疫苗(06660)盘中下跌5.09%,截至14:44,报6.15元/股,成交1083.17万元。艾美疫苗股份有限公司是中国第二大疫苗供应商,涵盖了从研发到制造、再到商业化的整个价值链,并在全球范围内拥有五种经过验证的人用疫苗平台技术。2021年销售收入市场份额为2.1%,批签发量在所有民营疫苗公司中处于领先地位,同时也是中国首批获得P3实验室建设许可的疫苗企业之一。截至2024年中报,艾美疫苗营业总收入5.37亿元、净利润-1.39亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/17144446464758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2492989816","title":"艾美疫苗盘中异动 下午盘大幅下挫5.09%报6.150港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492989816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492989816?lang=zh_cn&edition=full","pubTime":"2024-12-17 14:44","pubTimestamp":1734417863,"startTime":"0","endTime":"0","summary":"2024年12月17日下午盘14时44分,艾美疫苗股票出现波动,股价急速跳水5.09%。截至发稿,该股报6.150港元/股,成交量171.32万股,换手率0.35%,振幅5.71%。资金方面,该股资金流入234.377万港元,流出538.077万港元。艾美疫苗股票所在的药品行业中,整体跌幅为0.07%。其相关个股中,雅各臣科研制药、东阳光长江药业、康哲药业涨幅较大,振幅较大的相关个股有李氏大药厂、顺腾国际控股、联康生物科技集团,振幅分别为11.43%、11.11%、9.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217144423a1f50b76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217144423a1f50b76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06660"],"gpt_icon":0},{"id":"2491434686","title":"南向资金12月13日净卖出艾美疫苗17.22万股 连续7日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2491434686","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491434686?lang=zh_cn&edition=full","pubTime":"2024-12-16 09:30","pubTimestamp":1734312623,"startTime":"0","endTime":"0","summary":"12月13日,南向资金减持艾美疫苗17.22万股连续7日减持。截止当日收盘,港股通共持有艾美疫苗6114.10万股,占流通股12.41%。艾美疫苗近5个交易日下跌3.81%,港股通累计减持70.36万股;近20个交易日下跌6.01%,港股通累计增持199.04万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216093315ab7afa7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216093315ab7afa7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06660"],"gpt_icon":0},{"id":"2490467318","title":"南向资金12月11日净卖出艾美疫苗29.82万股 连续5日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2490467318","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490467318?lang=zh_cn&edition=full","pubTime":"2024-12-12 09:30","pubTimestamp":1733967026,"startTime":"0","endTime":"0","summary":"12月11日,南向资金减持艾美疫苗29.82万股连续5日减持。截止当日收盘,港股通共持有艾美疫苗6142.70万股,占流通股12.47%。艾美疫苗近5个交易日上涨1.61%,港股通累计减持50.38万股;近20个交易日下跌11.69%,港股通累计增持379.42万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212093319a1e7a9c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212093319a1e7a9c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06660"],"gpt_icon":0},{"id":"2490106621","title":"艾美疫苗12月10日遭主力抛售116万元 环比增加107.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490106621","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490106621?lang=zh_cn&edition=full","pubTime":"2024-12-10 16:16","pubTimestamp":1733818616,"startTime":"0","endTime":"0","summary":"12月10日, 艾美疫苗股价跌2.16%,报收6.80元,成交金额2963万元,换手率0.86%,振幅5.76%,量比1.77。艾美疫苗今日主力资金净流出116万元,连续4日净流出,上一交易日主力净流出56万元,今日环比增加107.14%。近一年数据显示,该股主力连续4日净流出后,次日下跌概率为50.00%,平均跌幅为0.76%。该股近5个交易日下跌5.01%,主力资金累计净流出430万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出340万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210161755a1e2d3ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210161755a1e2d3ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2490318870","title":"南向资金12月9日净卖出艾美疫苗9.66万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2490318870","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490318870?lang=zh_cn&edition=full","pubTime":"2024-12-10 09:30","pubTimestamp":1733794229,"startTime":"0","endTime":"0","summary":"12月9日,南向资金减持艾美疫苗9.66万股连续3日减持。截止当日收盘,港股通共持有艾美疫苗6174.80万股,占流通股12.54%。艾美疫苗近5个交易日下跌3.20%,港股通累计减持7.10万股;近20个交易日下跌10.78%,港股通累计增持476.50万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210093311a1e1eec9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210093311a1e1eec9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2490674569","title":"艾美疫苗12月09日主力资金流出56万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2490674569","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490674569?lang=zh_cn&edition=full","pubTime":"2024-12-09 16:16","pubTimestamp":1733732164,"startTime":"0","endTime":"0","summary":"12月09日, 艾美疫苗股价涨1.76%,报收6.95元,成交金额1725万元,换手率0.52%,振幅3.95%,量比1.08。艾美疫苗今日主力资金净流出56万元,连续3日净流出,上一交易日主力净流出114万元,今日环比减少50.88%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为62.50%,平均跌幅为3.49%。该股近5个交易日下跌3.20%,主力资金累计净流出314万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出170万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209161626a1dfddc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209161626a1dfddc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06660"],"gpt_icon":0},{"id":"2489369179","title":"南向资金12月4日净买入艾美疫苗2.52万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2489369179","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489369179?lang=zh_cn&edition=full","pubTime":"2024-12-05 09:30","pubTimestamp":1733362218,"startTime":"0","endTime":"0","summary":"12月4日, 南向资金增持艾美疫苗2.52万股,连续3日增持。截止当日收盘,港股通共持有艾美疫苗6193.08万股,占流通股12.57%。艾美疫苗近5个交易日下跌7.57%,港股通累计增持122.36万股;近20个交易日下跌14.93%,港股通累计增持517.70万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205093222ab5e6043&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205093222ab5e6043&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06660"],"gpt_icon":0},{"id":"2486364054","title":"艾美疫苗11月28日遭主力抛售44万元 环比增加780.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486364054","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486364054?lang=zh_cn&edition=full","pubTime":"2024-11-28 16:15","pubTimestamp":1732781727,"startTime":"0","endTime":"0","summary":"11月28日, 艾美疫苗股价跌3.65%,报收7.13元,成交金额1820万元,换手率0.51%,振幅5.54%,量比0.39。艾美疫苗今日主力资金净流出44万元,连续3日净流出,上一交易日主力净流出5万元,今日环比增加780.00%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为75.00%,平均跌幅为3.39%。该股近5个交易日上涨2.44%,主力资金累计净流入268万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出2053万元,其中净流出天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128161543abe553c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128161543abe553c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06660"],"gpt_icon":0},{"id":"2486886546","title":"艾美疫苗盘中异动 早盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486886546","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486886546?lang=zh_cn&edition=full","pubTime":"2024-11-27 09:38","pubTimestamp":1732671501,"startTime":"0","endTime":"0","summary":"2024年11月27日早盘09时38分,艾美疫苗股票出现波动,股价急速上涨5.04%。截至发稿,该股报7.710港元/股,成交量66.16万股,换手率0.13%,振幅5.86%。资金方面,该股资金流入218.089万港元,流出97.6426万港元。艾美疫苗股票所在的药品行业中,整体涨幅为0.00%。其相关个股中,泰凌医药、艾美疫苗、德琪医药-B涨幅较大,振幅较大的相关个股有德琪医药-B、艾美疫苗、君圣泰医药-B,振幅分别为7.58%、5.86%、2.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127093822971a8c00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127093822971a8c00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2486693016","title":"港股异动 | 艾美疫苗(06660)午前飙升近14% 两大重磅疫苗接近上市 公司近日迎来多家机构调研","url":"https://stock-news.laohu8.com/highlight/detail?id=2486693016","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486693016?lang=zh_cn&edition=full","pubTime":"2024-11-26 11:47","pubTimestamp":1732592841,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,艾美疫苗午前飙升近14%,截至发稿,涨13.93%,报7.85港元,成交额3919.87万港元。消息面上,11月15日,据国家药品监督管理局药品审评中心显示,艾美疫苗研发的13价结合肺炎疫苗的上市注册获受理。据悉,艾美疫苗11月21日举办了2024年投资者开放日活动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1215850.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06660","159646"],"gpt_icon":0},{"id":"2486019524","title":"艾美疫苗(06660)股价显著上升11.321%,现价港币$7.67","url":"https://stock-news.laohu8.com/highlight/detail?id=2486019524","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486019524?lang=zh_cn&edition=full","pubTime":"2024-11-26 11:42","pubTimestamp":1732592520,"startTime":"0","endTime":"0","summary":"[上升股]艾美疫苗(06660) 股价在上午11:42比前收市价显著上升11.321%,现股价为港币$7.67。至目前为止,今日最高价为$7.67,而最低价为$6.81。总成交量为376.66万股,总成交金额为港币$2.715千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152552334_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152552334_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2411261310/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","06660"],"gpt_icon":0},{"id":"2486019307","title":"艾美疫苗(06660)上涨5.08%,报7.24元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2486019307","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486019307?lang=zh_cn&edition=full","pubTime":"2024-11-26 11:37","pubTimestamp":1732592257,"startTime":"0","endTime":"0","summary":"11月26日,艾美疫苗(06660)盘中上涨5.08%,截至11:37,报7.24元/股,成交1396.43万元。艾美疫苗股份有限公司是中国第二大疫苗供应商,涵盖了从研发到制造、再到商业化的整个价值链,并在全球范围内拥有五种经过验证的人用疫苗平台技术。2021年销售收入市场份额为2.1%,批签发量在所有民营疫苗公司中处于领先地位,同时也是中国首批获得P3实验室建设许可的疫苗企业之一。截至2024年中报,艾美疫苗营业总收入5.37亿元、净利润-1.39亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/26113745678295.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","06660"],"gpt_icon":0},{"id":"2486722806","title":"艾美疫苗盘中异动 下午盘股价大涨5.03%报6.890港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486722806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486722806?lang=zh_cn&edition=full","pubTime":"2024-11-25 13:05","pubTimestamp":1732511144,"startTime":"0","endTime":"0","summary":"2024年11月25日下午盘13时05分,艾美疫苗股票出现波动,股价急速上涨5.03%。截至发稿,该股报6.890港元/股,成交量159.82万股,换手率0.32%,振幅4.88%。资金方面,该股资金流入558.917万港元,流出251.293万港元。艾美疫苗股票所在的药品行业中,整体跌幅为0.04%。其相关个股中,三爱健康集团、泰凌医药、艾美疫苗涨幅较大,振幅较大的相关个股有泰凌医药、三爱健康集团、德琪医药-B,振幅分别为26.00%、16.28%、12.12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112513054498e4452c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112513054498e4452c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06660"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aimbio.com","stockEarnings":[{"period":"1week","weight":-0.1198},{"period":"1month","weight":-0.1408},{"period":"3month","weight":0.4319},{"period":"6month","weight":-0.1504},{"period":"1year","weight":-0.1609},{"period":"ytd","weight":-0.2229}],"compareEarnings":[{"period":"1week","weight":-0.0316},{"period":"1month","weight":0.0045},{"period":"3month","weight":0.0818},{"period":"6month","weight":0.0956},{"period":"1year","weight":0.1889},{"period":"ytd","weight":0.1587}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"艾美疫苗股份有限公司是一家主要从事疫苗研发、制造和销售的中国公司。该公司的产品主要包括重组乙型肝炎疫苗、人用狂犬病疫苗、甲型肝炎灭活疫苗、腮腺炎疫苗、肾综合征出血热灭活疫苗和MPSV4。该公司的产品主要用于治疗乙肝、甲肝、腮腺炎、肾综合征出血热、狂犬病和脑膜炎球菌病。该公司的在研疫苗包括信使核糖核酸(mRNA)新冠(COVID-19)疫苗、灭活新冠疫苗、广谱新冠疫苗、PCV13、PPSV23及MCV4。该公司主要在国内市场开展业务。","exchange":"SEHK","name":"艾美疫苗","nameEN":"AIM VACCINE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾美疫苗(06660)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾美疫苗(06660)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾美疫苗,06660,艾美疫苗股票,艾美疫苗股票老虎,艾美疫苗股票老虎国际,艾美疫苗行情,艾美疫苗股票行情,艾美疫苗股价,艾美疫苗股市,艾美疫苗股票价格,艾美疫苗股票交易,艾美疫苗股票购买,艾美疫苗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾美疫苗(06660)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾美疫苗(06660)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}